PMID- 26125093
OWN - NLM
STAT- MEDLINE
DCOM- 20151203
LR  - 20220311
IS  - 1557-7449 (Electronic)
IS  - 1087-2914 (Linking)
VI  - 29
IP  - 8
DP  - 2015 Aug
TI  - Evaluating the Effects of an Interdisciplinary Practice Model with Pharmacist 
      Collaboration on HIV Patient Co-Morbidities.
PG  - 445-53
LID - 10.1089/apc.2015.0018 [doi]
AB  - Treatment of HIV now occurs largely within the primary care setting, and the 
      principal focus of most visits has become the management of chronic disease 
      states. The clinical pharmacist's potential role in improving chronic disease 
      outcomes for HIV patients is unknown. A retrospective cohort study was performed 
      for HIV-positive patients also diagnosed with diabetes, hypertension, or 
      hyperlipidemia. Characteristics and outcomes in 96 patients treated by an 
      interdisciplinary team that included a clinical pharmacist (i.e., the 
      intervention group) were compared to those in 50 patients treated by an 
      individual healthcare provider (i.e., the control group). Primary outcomes were 
      changes from baseline over 18 months of HbA1c, low density lipoprotein (LDL), and 
      blood pressure, respectively. Secondary outcomes included number of drug-drug 
      interactions, HIV viral load, CD4 count, percent change in smoking status, and 
      percent of patients treated to cardiovascular guideline recommendations. The 
      interdisciplinary team had a significant improvement in lipid management over the 
      control group (LDL: -8.8 vs. +8.4 mg/dL; p=0.014), and the smoking cessation rate 
      over the study period was doubled in the interdisciplinary group (20.4% vs. 
      11.8%). Among those with an indication for aspirin, a significantly higher 
      percentage of patients were prescribed the medication in the interdisciplinary 
      group compared to the control group (85.5% vs. 64.9%; p=0.014). An informal cost 
      analysis estimated savings of more than $3000 per patient treated by the 
      interdisciplinary team. Based on these results, pharmacist involvement in an HIV 
      primary care clinic appears to lead to more appropriate management of chronic 
      co-morbidities in a cost-effective manner.
FAU - Cope, Rebecca
AU  - Cope R
AD  - 1 Touro College of Pharmacy , New York, New York.
FAU - Berkowitz, Leonard
AU  - Berkowitz L
AD  - 2 Division of Infectious Diseases, The Brooklyn Hospital Center , Brooklyn, New 
      York.
FAU - Arcebido, Rebecca
AU  - Arcebido R
AD  - 3 Pharmacotherapy Services, The Brooklyn Hospital Center , Brooklyn, New York.
FAU - Yeh, Jun-Yen
AU  - Yeh JY
AD  - 4 College of Pharmacy, Long Island University , Brooklyn, New York.
FAU - Trustman, Nathan
AU  - Trustman N
AD  - 4 College of Pharmacy, Long Island University , Brooklyn, New York.
FAU - Cha, Agnes
AU  - Cha A
AD  - 4 College of Pharmacy, Long Island University , Brooklyn, New York.
LA  - eng
PT  - Journal Article
DEP - 20150630
PL  - United States
TA  - AIDS Patient Care STDS
JT  - AIDS patient care and STDs
JID - 9607225
SB  - IM
MH  - Adult
MH  - Aged
MH  - Cardiovascular Diseases/epidemiology
MH  - Comorbidity
MH  - Diabetes Mellitus, Type 2/epidemiology
MH  - Female
MH  - HIV Infections/epidemiology/*therapy
MH  - Humans
MH  - Hypertension/epidemiology
MH  - *Interprofessional Relations
MH  - Male
MH  - Middle Aged
MH  - Outcome Assessment, Health Care
MH  - *Patient Care Team
MH  - *Pharmaceutical Services
MH  - Physicians
MH  - Primary Health Care/*methods
MH  - Professional Role
MH  - Program Evaluation
MH  - Retrospective Studies
EDAT- 2015/07/01 06:00
MHDA- 2015/12/15 06:00
CRDT- 2015/07/01 06:00
PHST- 2015/07/01 06:00 [entrez]
PHST- 2015/07/01 06:00 [pubmed]
PHST- 2015/12/15 06:00 [medline]
AID - 10.1089/apc.2015.0018 [doi]
PST - ppublish
SO  - AIDS Patient Care STDS. 2015 Aug;29(8):445-53. doi: 10.1089/apc.2015.0018. Epub 
      2015 Jun 30.